Page last updated: 2024-10-31

nocodazole and Multiple Myeloma

nocodazole has been researched along with Multiple Myeloma in 2 studies

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference
"We identified nocodazole as a potent antimyeloma drug from a drug screening library provided by the Multiple Myeloma Research Foundation."3.77Targeting the microtubular network as a new antimyeloma strategy. ( Andreas, C; Feng, R; Lentzsch, S; Li, S; Lu, C; Mapara, MY; Stolz, DB, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, R1
Li, S1
Lu, C1
Andreas, C1
Stolz, DB1
Mapara, MY1
Lentzsch, S1
Díaz-Rodríguez, E1
Álvarez-Fernández, S1
Chen, X1
Paiva, B1
López-Pérez, R1
García-Hernández, JL1
San Miguel, JF1
Pandiella, A1

Other Studies

2 other studies available for nocodazole and Multiple Myeloma

ArticleYear
Targeting the microtubular network as a new antimyeloma strategy.
    Molecular cancer therapeutics, 2011, Volume: 10, Issue:10

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Gro

2011
Deficient spindle assembly checkpoint in multiple myeloma.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Aneuploidy; Calcium-Binding Proteins; Cell Cycle Proteins; Cell Line, Tumor; Gene Expression Regulat

2011